tetano
Editor, Senior Moderator
Expert Rev Anti Infect Ther. 2015 Apr 3:1-9. [Epub ahead of print]
[h=1]Antiviral treatment of influenza in South Korea.[/h] Choe YJ[SUP]1[/SUP], Lee H, Lee HJ, Choi EH.
[h=3]Author information[/h]
[h=3]Abstract[/h] Antiviral therapy has an important role in the treatment and chemoprophylaxis of influenza. At present, two classes of antiviral agents, adamantanes and neuraminidase inhibitors, are available for the treatment and chemoprophylaxis of influenza in Korea. Because of the widespread resistance against adamantanes, neuraminidase inhibitors are mainly used. Because each country has a unique epidemiology of influenza, the proper use of antiviral agents should be determined based on local data. Decisions on the clinical practice in the treatment of influenza in South Korea are guided by the local surveillance data, practice guidelines, health insurance system and the resistance patterns of the circulating influenza viruses. This review highlights the role of antiviral agents in the treatment and outcome of influenza in Korea by providing comprehensive information of their clinical usage in Korea.
[h=4]KEYWORDS:[/h] Influenza; Korea; chemoprophylaxis; neuraminidase inhibitor; treatment
PMID: 25835433 [PubMed - as supplied by publisher]
[h=1]Antiviral treatment of influenza in South Korea.[/h] Choe YJ[SUP]1[/SUP], Lee H, Lee HJ, Choi EH.
[h=3]Author information[/h]
[h=3]Abstract[/h] Antiviral therapy has an important role in the treatment and chemoprophylaxis of influenza. At present, two classes of antiviral agents, adamantanes and neuraminidase inhibitors, are available for the treatment and chemoprophylaxis of influenza in Korea. Because of the widespread resistance against adamantanes, neuraminidase inhibitors are mainly used. Because each country has a unique epidemiology of influenza, the proper use of antiviral agents should be determined based on local data. Decisions on the clinical practice in the treatment of influenza in South Korea are guided by the local surveillance data, practice guidelines, health insurance system and the resistance patterns of the circulating influenza viruses. This review highlights the role of antiviral agents in the treatment and outcome of influenza in Korea by providing comprehensive information of their clinical usage in Korea.
[h=4]KEYWORDS:[/h] Influenza; Korea; chemoprophylaxis; neuraminidase inhibitor; treatment
PMID: 25835433 [PubMed - as supplied by publisher]